Overview

Antidepressant Therapy for Bipolar II Major Depression

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study examines the relative safety and benefit of antidepressant therapy (versus recommended mood stabilizer therapy)of bipolar type II major depressive episode. We hypothesize that antidepressant therapy will be superior to mood stabilizer therapy with little or no difference in treatment emergent manic symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Stanley Medical Research Institute
Treatments:
Antidepressive Agents
Lithium Carbonate
Venlafaxine Hydrochloride